Page 70 - Read Online
P. 70

Page 12 of 14              Abdel-Halim et al. Vessel Plus 2022;6:8  https://dx.doi.org/10.20517/2574-1209.2021.40

               considered and tailored according to the needs of each patient in a way that improves his/her quality of
                  [55]
               life .
               CONCLUSION
               Cutaneous manifestations are common in AAV. They may be the presenting manifestation of the disease,
               occur during its course, or mark a disease relapse. They may be specific or non-specific according to the
               presence or absence of vasculitis with or without granulomas in skin biopsies. They are usually associated
               with severe systemic manifestations and multiple organ involvement. Since such lesions can occur in other
               types of systemic vasculitis and in other disorders, linking them with AAV requires meticulous clinical,
               laboratory, and serological correlation.

               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to conception and design of the manuscript, writing, editing, provision of
               clinical photos and histopathological photomicrographs: Abdel-Halim M
               Contributed to writing the manuscript: Mahmoud A
               Planning, supervising, revision of the manuscript and editing: Ragab G


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U. ANCA-associated vasculitis - clinical utility of using ANCA specificity to
                   classify patients. Nat Rev Rheumatol 2016;12:570-9.  DOI  PubMed
               2.       Micheletti RG, Chiesa Fuxench Z, Craven A, Watts RA, Luqmani RA, Merkel PA; DCVAS Investigators. Cutaneous manifestations
                   of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 2020;72:1741-7.  DOI  PubMed
               3.       Francès C, Du LT, Piette JC, et al. Wegener’s granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic
                   correlation. Arch Dermatol 1994;130:861-7.  PubMed
               4.       Kluger N, Pagnoux C, Guillevin L, Francès C; French Vasculitis Study Group. Comparison of cutaneous manifestations in systemic
                   polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol 2008;159:615-20.  DOI  PubMed
               5.       Comarmond C, Pagnoux C, Khellaf M, et al; French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-
                   Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
                   Arthritis Rheum 2013;65:270-81.  DOI  PubMed
               6.       Ragab G, Hegazy MT, Ali M, Abdel-Halim MRE, Puéchal X. Three patterns of cutaneous involvement in granulomatosis with
                   polyangiitis. J Adv Res 2020;24:311-5.  DOI  PubMed  PMC
               7.       Daoud MS, Gibson LE, Deremee RA, Specks U, el-Azhary RA, Daniel Su W. Cutaneous Wegener's granulomatosis: clinical,
                   histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 1994;31:605-12.  DOI  PubMed
   65   66   67   68   69   70   71   72   73   74   75